See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Bristol Myers Squibb Company (BMY) - free report >>
Curis, Inc. (CRIS) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Bristol Myers Squibb Company (BMY) - free report >>
Curis, Inc. (CRIS) - free report >>
Image: Bigstock
New Strong Buy Stocks for December 13th
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Xperi Corporation (XPER - Free Report) : This developer of audio, imaging, semiconductor packaging, and interconnect technologies has seen the Zacks Consensus Estimate for its current year earnings increasing 5.5% over the last 60 days.
Tessera Holding Corporation Price and Consensus
Tessera Holding Corporation price-consensus-chart | Tessera Holding Corporation Quote
Bristol-Myers Squibb Company (BMY - Free Report) : This developer and distributor of biopharmaceutical products has seen the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.
Bristol-Myers Squibb Company Price and Consensus
Bristol-Myers Squibb Company price-consensus-chart | Bristol-Myers Squibb Company Quote
Catabasis Pharmaceuticals, Inc. : This owner and operator of a clinical-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 36% over the last 60 days.
Catabasis Pharmaceuticals, Inc. Price and Consensus
Catabasis Pharmaceuticals, Inc. price-consensus-chart | Catabasis Pharmaceuticals, Inc. Quote
Clarus Corporation (CLAR - Free Report) : This manufacturer of outdoor equipment and lifestyle products has seen the Zacks Consensus Estimate for its current year earnings increasing 14.6% over the last 60 days.
Clarus Corporation Price and Consensus
Clarus Corporation price-consensus-chart | Clarus Corporation Quote
Curis, Inc. (CRIS - Free Report) : This owner and operator of a biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 12.7% over the last 60 days.
Curis, Inc. Price and Consensus
Curis, Inc. price-consensus-chart | Curis, Inc. Quote
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>